GenomOncology Enhances The GO Clinical Workbench For Hematological Cancer Analysis And Reporting

GenomOncology today announced the recent extension of the GO Clinical Workbench to support Hematologic cancer testing and decision support.

Molecular diagnostic laboratories across the country have used GenomOncology’s workbench for their solid tumor testing needs for over two years. GenomOncology’s clients have recently begun to validate and launch Hematologic malignancy focused panels. With new guidelines and content about Hematologic malignancies becoming available, GenomOncology utilized the GO Clinical Workbench and its Knowledge Management System (KMS) to enable accurate reporting of advanced molecular testing. To enable the vision of molecular pathologists and to meet the needs of clinicians, new features and workflows were developed to increase flexibility, while maintaining CLIA/CAP guidelines.

Click here to read the full article